St. Louis encephalitis: Difference between revisions

Jump to navigation Jump to search
Zorkun (talk | contribs)
No edit summary
 
Zorkun (talk | contribs)
Line 17: Line 17:


[[Image:Cases by year.jpg|left|frame|Human St. Louis encephalitis cases by year, 1964 - 2005]]
[[Image:Cases by year.jpg|left|frame|Human St. Louis encephalitis cases by year, 1964 - 2005]]
 
<br clear="left"/>


The mortality rate from St. Louis encephalitis ranges from 5 to 30%, with higher rates among the elderly.
The mortality rate from St. Louis encephalitis ranges from 5 to 30%, with higher rates among the elderly.

Revision as of 02:01, 16 January 2009

WikiDoc Resources for St. Louis encephalitis

Articles

Most recent articles on St. Louis encephalitis

Most cited articles on St. Louis encephalitis

Review articles on St. Louis encephalitis

Articles on St. Louis encephalitis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on St. Louis encephalitis

Images of St. Louis encephalitis

Photos of St. Louis encephalitis

Podcasts & MP3s on St. Louis encephalitis

Videos on St. Louis encephalitis

Evidence Based Medicine

Cochrane Collaboration on St. Louis encephalitis

Bandolier on St. Louis encephalitis

TRIP on St. Louis encephalitis

Clinical Trials

Ongoing Trials on St. Louis encephalitis at Clinical Trials.gov

Trial results on St. Louis encephalitis

Clinical Trials on St. Louis encephalitis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on St. Louis encephalitis

NICE Guidance on St. Louis encephalitis

NHS PRODIGY Guidance

FDA on St. Louis encephalitis

CDC on St. Louis encephalitis

Books

Books on St. Louis encephalitis

News

St. Louis encephalitis in the news

Be alerted to news on St. Louis encephalitis

News trends on St. Louis encephalitis

Commentary

Blogs on St. Louis encephalitis

Definitions

Definitions of St. Louis encephalitis

Patient Resources / Community

Patient resources on St. Louis encephalitis

Discussion groups on St. Louis encephalitis

Patient Handouts on St. Louis encephalitis

Directions to Hospitals Treating St. Louis encephalitis

Risk calculators and risk factors for St. Louis encephalitis

Healthcare Provider Resources

Symptoms of St. Louis encephalitis

Causes & Risk Factors for St. Louis encephalitis

Diagnostic studies for St. Louis encephalitis

Treatment of St. Louis encephalitis

Continuing Medical Education (CME)

CME Programs on St. Louis encephalitis

International

St. Louis encephalitis en Espanol

St. Louis encephalitis en Francais

Business

St. Louis encephalitis in the Marketplace

Patents on St. Louis encephalitis

Experimental / Informatics

List of terms related to St. Louis encephalitis

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

St. Louis encephalitis is one of the most common mosquito-transmitted human pathogens in the United States.

References

http://www.cdc.gov/ncidod/dvbid/sle/index.html

Epidemiology and Demographics

St. Louis encephalitis is a viral disease that is spread to humans through the bite of infected mosquitoes. St. Louis encephalitis is found throughout much of the United States, as well as parts of Canada, the Caribbean, and South America.

In the United States, the leading cause of epidemic flaviviral encephalitis is St. Louis encephalitis (SLE) virus. SLE is the most common mosquito-transmitted human pathogen in the U.S. While periodic SLE epidemics have occurred only in the Midwest and southeast, SLE virus is distributed throughout the lower 48 states. Since 1964, there have been 4,437 confirmed cases of SLE with an average of 193 cases per year (range 4 - 1,967). However, less than 1% of SLE viral infections are clinically apparent and the vast majority of infections remain undiagnosed. Illness ranges in severity from a simple febrile headache to meningoencephalitis, with an overall case-fatality ratio of 5-15 %. The disease is generally milder in children than in adults, but in those children who do have disease, there is a high rate of encephalitis. During the summer season, SLE virus is maintained in a mosquito-bird-mosquito cycle, with periodic amplification by peridomestic birds and Culex mosquitoes. In Florida, the principal vector is Cx. nigripalpus, in the Midwest, Cx. pipiens pipiens and Cx. p. quinquefasciatus and in the western United States, Cx. tarsalis and members of the Cx. pipiens complex.

Human St. Louis encephalitis cases by state, 1964 - 2005


Human St. Louis encephalitis cases by year, 1964 - 2005


The mortality rate from St. Louis encephalitis ranges from 5 to 30%, with higher rates among the elderly.

References

http://www.cdc.gov/ncidod/dvbid/sle/Sle_FactSheet.html

http://www.cdc.gov/ncidod/dvbid/arbor/arbdet.htm

http://www.cdc.gov/ncidod/dvbid/sle/images/SLE1964_2005.jpg

http://www.cdc.gov/ncidod/dvbid/sle/Sle_ByYear.html

Risk Factors

The elderly are at highest risk for severe disease and death.

References

http://www.cdc.gov/ncidod/dvbid/arbor/arbdet.htm

Pathophysiology & Etiology

Image of culex tarsalis
Image of culex tarsalis

St. Louis encephalitis virus is a member of the genus Flavivirus, family Flaviviridae. Other similar diseases are West Nile virus, eastern equine encephalitis, western equine encephalitis, and La Crosse encephalitis.

St. Louis encephalitis virus is transmitted to humans through the bite of an infected mosquito. All residents of and visitors to areas where virus activity has been identified are at risk of getting St. Louis encephalitis, particularly persons living in crowded, low-income areas, and those who engage in outdoor work and recreational activities. St. Louis encephalitis virus infection is thought to confer life-long immunity against re-infection with St. Louis encephalitis virus.

During the summer season, St. Louis encephalitis virus is maintained in a mosquito-bird-mosquito cycle, with periodic amplification by peridomestic birds and Culex species mosquitoes. In Florida, the principal vector is Culex nigripalpus, in the Midwest, Culex pipiens and Culex quinquefasciatus and in the western United States, Culex tarsalis and members of the Culex pipiens complex.


What is the basic St. Louis encephalitis virus transmission cycle?

Mosquitoes (primarily the Culex species) become infected by feeding on birds infected with the St. Louis encephalitis virus. Infected mosquitoes then transmit the St. Louis encephalitis virus to humans and animals during the feeding process. The St. Louis encephalitis virus grows both in the infected mosquito and the infected bird, but does not make either one sick.


What is the incubation period for St. Louis encephalitis?

The incubation period (time from infection to illness) is usually five to 15 days.

References

http://www.cdc.gov/ncidod/dvbid/sle/Sle_FactSheet.html

http://www.cdc.gov/ncidod/dvbid/sle/Sle_Transmission.html

Natural History

St. Louis encephalitis virus is a flavivirus that was first identified in St. Louis, Missouri in 1933.

References

http://www.cdc.gov/ncidod/dvbid/sle/index.html

Diagnosis

Laboratory diagnosis of St. Louis encephalitis virus infection is generally detected through testing (ELISA or MIA or PRNT) of serum or CSF to detect virus-specific IgM and neutralizing antibodies.

In fatal cases, PCR, histopathology with immunohistochemistry, and virus culture of autopsy tissues continue to be useful. Only a few state laboratories or other specialized laboratories, including those at CDC, are capable of doing this specialized testing.

Differential Diagnosis

References

http://www.cdc.gov/ncidod/dvbid/sle/Sle_Diagnosis.html

History and Symptoms

Less than 1% of St. Louis encephalitis viral infections are clinically apparent and the vast majority of infections remain undiagnosed. Illness ranges in severity from a simple febrile headache to meningoencephalitis, with an overall case-fatality ratio of 5 to 15%. The disease is generally milder in children than in adults, but in those children who do have disease, there is a high rate of encephalitis (inflammation of the brain). The elderly are at highest risk for severe disease and death.

References

http://www.cdc.gov/ncidod/dvbid/sle/Sle_Symptoms.html


Hands opening pain reliever bottle.
Hands opening pain reliever bottle.

No vaccine or specific antiviral treatment for St. Louis encephalitis is available. Treatment is based on symptoms. Rest, fluids, and ibuprofen, naproxen, acetaminophen, or paracetamol may relieve symptoms of fever and aching. Aspirin should be avoided. Care of patients depends upon the severity of symptoms and complications.

Pharmacotherapy

References

http://www.cdc.gov/ncidod/dvbid/sle/Sle_FactSheet.html

Primary Prevention

There is no vaccine to prevent St. Louis encephalitis in humans. Reducing exposure to mosquitoes is the best defense against St. Louis encephalitis and other mosquito-borne diseases. There are several approaches you and your family can use to prevent and control mosquito-borne diseases.


Avoid Mosquito Bites

  • Use Insect Repellent. On exposed skin when you go outdoors, use an EPA-registered insect repellent such as those with DEET, picaridin or oil of lemon eucalyptus. Even a short time being outdoors can be long enough to get a mosquito bite. *Wear Proper Clothing to Reduce Mosquito Bites. When weather permits, wear long-sleeves, long pants and socks when outdoors. Mosquitoes may bite through thin clothing, so spraying clothes with repellent containing permethrin or another EPA-registered repellent will give extra protection. Do not apply repellents containing permethrin directly to skin. Do not spray repellent on the skin under your clothing.
  • Be Aware of Peak Mosquito Hours. The hours from dusk to dawn are peak biting times for many species of mosquitoes. Take extra care to use repellent and protective clothing during evening and early morning or consider avoiding outdoor activities during these times.


Mosquito-Proof Your Home and Community

  • Drain Standing Water. Mosquitoes lay their eggs in standing water. Limit the number of places around your home for mosquitoes to breed by getting rid of items that hold water.
  • Install or Repair Screens. Some mosquitoes like to come indoors. Keep them outside by having well-fitting screens on both windows and doors. Offer to help neighbors whose screens might be in bad shape.
  • Clean Up. Mosquito breeding sites can be anywhere. Neighborhood clean up days can be organized by civic or youth organizations to pick up containers from vacant lots and parks, and to encourage people to keep their yards free of standing water. Mosquitoes do not care about fences, so it is important to control breeding sites throughout the neighborhood.
  • Look into Mosquito Control Programs. Check with local health authorities to see if there is an organized mosquito control program in your area. If no program exists, work with your local government officials to establish a program.
References

http://www.cdc.gov/ncidod/dvbid/sle/Sle_Prevention.html

Acknowledgements

The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.


Template:SIB


Template:WH Template:WS